Want to join the conversation?
Based on its strong 3Q16 results, $ABC raised its FY16 earnings outlook to $5.52 to $5.57 per share from its previous outlook of $5.44 to $5.54 per share. $ABC added that it expects 4Q16 gross profit to remain under pressure due to weaker generic pricing trends as well as lower contributions from new generic drugs.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.